Provider and procedural factors associated with guideline-concordant lymph node sampling in lung cancer resection
- 4 May 2025
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 170 (3) , 864-875.e2
Abstract
No abstract availableKeywords
Funding Information
- Blue Cross Blue Shield of Michigan Foundation
This publication has 42 references indexed in Scilit:
- The American Cancer Society National Lung Cancer Roundtable strategic plan: Promoting guideline‐concordant lung cancer stagingCancer, 2024
- Higher Long-term Quality of Life Metrics After Video-Assisted Thoracoscopic Surgery Lobectomy Compared With Robotic-Assisted LobectomyThe Annals of Thoracic Surgery, 2022
- Quality Improvement: Arterial Grafting Redux, 2010:2019The Annals of Thoracic Surgery, 2021
- Association of Pathologic Nodal Staging Quality With Survival Among Patients With Non–Small Cell Lung Cancer After Resection With Curative IntentJAMA Oncology, 2018
- Improved Lymph Node Staging in Early-Stage Lung Cancer in the National Cancer DatabaseThe Annals of Thoracic Surgery, 2017
- Prognostic Value of National Comprehensive Cancer Network Lung Cancer Resection Quality CriteriaThe Annals of Thoracic Surgery, 2017
- Lymph Node Assessment and Impact on Survival in Video-Assisted Thoracoscopic Lobectomy or SegmentectomyThe Annals of Thoracic Surgery, 2015
- Association of Hospital Participation in a Quality Reporting Program With Surgical Outcomes and Expenditures for Medicare BeneficiariesJAMA, 2015
- A Statewide Quality Collaborative for Process Improvement: Internal Mammary Artery UtilizationThe Annals of Thoracic Surgery, 2010
- The Society of Thoracic Surgeons General Thoracic Surgery DatabaseThe Annals of Thoracic Surgery, 2007